Compare AMAR REMEDIES with JYOTHY LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs JYOTHY LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES JYOTHY LABS AMAR REMEDIES/
JYOTHY LABS
 
P/E (TTM) x -0.5 14.1 - View Chart
P/BV x 0.1 0.6 10.3% View Chart
Dividend Yield % 0.0 1.9 -  

Financials

 AMAR REMEDIES   JYOTHY LABS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
JYOTHY LABS
Mar-19
AMAR REMEDIES/
JYOTHY LABS
5-Yr Chart
Click to enlarge
High Rs164487 33.7%   
Low Rs86171 50.3%   
Sales per share (Unadj.) Rs261.649.4 529.7%  
Earnings per share (Unadj.) Rs17.45.4 323.2%  
Cash flow per share (Unadj.) Rs22.36.2 358.7%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs100.7135.1 74.5%  
Shares outstanding (eoy) m26.16367.20 7.1%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x0.56.7 7.2%   
Avg P/E ratio x7.261.1 11.8%  
P/CF ratio (eoy) x5.652.9 10.6%  
Price / Book Value ratio x1.22.4 51.0%  
Dividend payout %055.7 0.0%   
Avg Mkt Cap Rs m3,270120,790 2.7%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m1632,076 7.9%   
Avg. sales/employee Rs ThNM6,927.3-  
Avg. wages/employee Rs ThNM793.1-  
Avg. net profit/employee Rs ThNM754.8-  
INCOME DATA
Net Sales Rs m6,84418,136 37.7%  
Other income Rs m21278 7.6%   
Total revenues Rs m6,86518,413 37.3%   
Gross profit Rs m1,1312,811 40.2%  
Depreciation Rs m128306 41.9%   
Interest Rs m398352 113.0%   
Profit before tax Rs m6262,430 25.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121454 26.6%   
Profit after tax Rs m4551,976 23.0%  
Gross profit margin %16.515.5 106.6%  
Effective tax rate %19.318.7 103.4%   
Net profit margin %6.610.9 61.0%  
BALANCE SHEET DATA
Current assets Rs m4,9046,218 78.9%   
Current liabilities Rs m3,5815,949 60.2%   
Net working cap to sales %19.31.5 1,304.7%  
Current ratio x1.41.0 131.0%  
Inventory Days Days12441 305.2%  
Debtors Days Days10031 324.5%  
Net fixed assets Rs m1,68911,149 15.1%   
Share capital Rs m26236,720 0.7%   
"Free" reserves Rs m2,35812,898 18.3%   
Net worth Rs m2,63549,618 5.3%   
Long term debt Rs m50720 2,509.9%   
Total assets Rs m6,86219,423 35.3%  
Interest coverage x2.67.9 32.6%   
Debt to equity ratio x0.20 47,262.4%  
Sales to assets ratio x1.00.9 106.8%   
Return on assets %12.412.0 103.7%  
Return on equity %17.34.0 433.6%  
Return on capital %31.05.6 553.0%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273358 76.3%   
Fx outflow Rs m2332 0.6%   
Net fx Rs m27126 1,050.8%   
CASH FLOW
From Operations Rs m-3133,016 -10.4%  
From Investments Rs m-489304 -160.8%  
From Financial Activity Rs m769-3,185 -24.1%  
Net Cashflow Rs m-33135 -24.1%  

Share Holding

Indian Promoters % 25.5 66.8 38.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 8.4 109.0%  
FIIs % 0.0 14.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 10.3 634.0%  
Shareholders   13,061 84,983 15.4%  
Pledged promoter(s) holding % 99.7 36.7 271.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   MARICO  GILLETTE INDIA  BATA INDIA  GODREJ CONSUMER  RELAXO FOOTWEARS  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Falling Crude Oil Prices, Key Q3FY20 Results, and Top Cues in Focus Today(Pre-Open)

On Monday, Indian share markets witnessed selling pressure throughout the day and ended deep in the red. Benchmark indices fell sharply amid weakness in global equities.

Related Views on News

JYOTHY LABS Announces Quarterly Results (2QFY20); Net Profit Up 17.4% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, JYOTHY LABS has posted a net profit of Rs 532 m (up 17.4% YoY). Sales on the other hand came in at Rs 5 bn (up 8.5% YoY). Read on for a complete analysis of JYOTHY LABS's quarterly results.

JYOTHY LABS 2018-19 Annual Report Analysis (Annual Result Update)

Oct 3, 2019 | Updated on Oct 3, 2019

Here's an analysis of the annual report of JYOTHY LABS for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JYOTHY LABS. Also includes updates on the valuation of JYOTHY LABS.

JYOTHY LABS Announces Quarterly Results (1QFY20); Net Profit Up 10.9% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, JYOTHY LABS has posted a net profit of Rs 359 m (up 10.9% YoY). Sales on the other hand came in at Rs 4 bn (up 1.6% YoY). Read on for a complete analysis of JYOTHY LABS's quarterly results.

JYOTHY LABS Announces Quarterly Results (4QFY19); Net Profit Up 11.1% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, JYOTHY LABS has posted a net profit of Rs 670 m (up 11.1% YoY). Sales on the other hand came in at Rs 5 bn (down 0.2% YoY). Read on for a complete analysis of JYOTHY LABS's quarterly results.

JYOTHY LABS Announces Quarterly Results (3QFY19); Net Profit Up 47.1% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, JYOTHY LABS has posted a net profit of Rs 484 m (up 47.1% YoY). Sales on the other hand came in at Rs 4 bn (up 0.7% YoY). Read on for a complete analysis of JYOTHY LABS's quarterly results.

More Views on News

Most Popular

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

The Best Asset Class to Invest in 2020(Fast Profits Daily)

Jan 24, 2020

Why I'm most bullish on this asset class above all else in 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS